AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life
2
How Israel’s AI surveillance breakthrough in Iran is reshaping global intelligence
3
Echo: “Employees have become very good at identifying performative culture”
4
Rylo raises $85 million at $500 million valuation, targets $1 billion revenue by 2028
5
Former Microsoft and Tesla security leaders emerge with $35 million for Pi
More news

ALS

6 stories about ALS
מימין ג'ון מדבד יו"ר OurCrowd ו כלי טשיל מנכ"ל ומנהל תפעול OurCrowd

Jon Medved steps down as OurCrowd CEO after ALS diagnosis

21.10.25|Meir Orbach
Founder passes the torch to Cali Chill as he moves into Chairman role and focuses on strategic growth. 
NeuroSense & NeuraLight R&D Teams

NeuroSense Therapeutics and NeuraLight collaborate to detect ALS using AI

28.07.22|CTech
The collaboration between the Israeli companies will help the scientific community better understand Amyotrophic lateral sclerosis (ALS) and develop effective drugs to treat it
מוסף שבועי 10.9.20 ד"ר פיטר סקוט־מורגן

Mind over Matter: The man who turned himself into a cyborg to overcome ALS

13.09.20|Yoghev Carmel
After Peter Scott-Morgan was given a year to live, he decided to fight his fate and employed cutting edge technology to stay alive and remain human
תרופה תרופות סל התרופות

ALS Drug Developer NeuroSense Crowdfunds $1.15 Million

05.08.19|Adi Pick
The company’s 1,114 new investors will jointly own a 10% stake, the company said
default image

Kadimastem Gets FDA Orphan Drug Designation for ALS Drug

04.11.18|Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019
חיים לייבוביץ' מנכ"ל בריינסטורם

Israeli ALS Treatment Developer Recruits Kite Pharma's CSO as Board Member

05.02.18|Dror Reich
Nasdaq-listed BrainStorm develops stem cell therapies for degenerative neurological diseases